Breast Cancer Screening Using Clinical Breast Examination: A Cost-Effectiveness Analysis for South Africa
CBE scale-up effectively saves life years but is not cost-effective under the country's opportunity cost-derived threshold of $3015/DALY averted. However, decisions on the best screening policy are not solely based on cost-effectiveness. They involve careful consideration of budgetary constraints and competing healthcare priorities. Scale-up should consider system capacity, minimum care standards and cost-effective early detection strategies.
Authors
- Noreen Dadirai Mdege (ORCID: https://orcid.org/0000-0003-3189-3473)
- Gesine Meyer‐Rath (ORCID: https://orcid.org/0000-0003-0439-381X)
- Naomi Lince-Deroche (ORCID: https://orcid.org/0000-0003-3689-4205)
- Alan Brennan (ORCID: https://orcid.org/0000-0002-1025-312X)
- Richard Muwonge (ORCID: https://orcid.org/0000-0002-3448-0503)
- Olena Mandrik (ORCID: https://orcid.org/0000-0003-3755-3031)
- Sithabiso Masuku (ORCID: https://orcid.org/0000-0001-7062-6322)
- Gauravi Mishra (ORCID: https://orcid.org/0000-0002-0154-7302)
Institutions
- Homi Bhabha National Institute (IN)
- Centre international de recherche sur le cancer (FR)
- University of Sheffield (GB)
Publication Details
- Journal
- Value in Health Regional Issues
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1016/j.vhri.2025.101127
- Citations
- 1
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Wellcome
- Wellcome Trust
- National Institute for Health and Care Research